| Deler fremragende | 29,912,305 shares |
| Insideraktier | 5.866.144 shares |
| Insider ejerskab | 19,61 % |
| Total Insiders | 28 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Acutus Medical, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| John Barnickel Chief Commercial Officer - [O] | 13.966 | 13.966 | |
| David P Bonita Director - [D] | 20.822 | 20.822 | |
| Vincent J Burgess Chief Executive Officer, Director - [D] [O] | 61.469 | 61.469 | |
| Daniella Cramp Director - [D] | 11.623 | 11.623 | |
|
Management Co Deerfield
Director, 10% Owner -
[D]
|
4.022 | 2.669.208 | |
|
Deerfield Partners, L.p.
Director, 10% Owner -
[D]
|
3.438.589 | 3.438.589 | |
|
Deerfield Mgmt III, L.P.
Director, 10% Owner -
[D]
|
3.438.589 | 3.438.589 | |
|
Deerfield Mgmt L.P.
Director, 10% Owner -
[D]
|
3.438.589 | 3.438.589 | |
|
Deerfield Private Design Fund III, L.P.
Director, 10% Owner -
[D]
|
3.438.589 | 3.438.589 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Doherty Gary W. Chief Financial Officer - [O] | 5.000 | 5.000 | |
| Andrew ElBardissi Director - [D] | 20.822 | 20.822 | |
| James E Flynn Director - [D] | 2.669.208 | 2.669.208 | |
| Jason K Garland Director - [D] | 22.400 | 22.400 | |
| Hinrichs James F. Director - [D] | 61.311 | 61.311 | |
| R Scott Huennekens Director - [D] | 529.349 | 529.349 | |
| Shahzad Malik Director - [D] | 4.022 | 4.022 | |
| Shaden Marzouk Director - [D] | 20.822 | 20.822 | |
| Kevin Mathews SVP, Commercial - [O] | 61.106 | 61.106 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Steven McQuillan SVP, Clinical Affairs & QA - [O] | 45.844 | 45.844 | |
| Takeo Mukai CFO - [O] | 72.874 | 72.874 | |
|
Orbimed Advisors Llc
Director, 10% Owner -
[D]
|
1.677.361 | 1.677.361 | |
|
OrbiMed Capital GP IV LLC
Director, 10% Owner -
[D]
|
1.677.361 | 1.677.361 | |
|
Orbimed ROF II LLC
Director, 10% Owner -
[D]
|
1.677.361 | 1.677.361 | |
| Niamh Louise Pellegrini Director - [D] | 20.972 | 20.972 | |
| Charlie Piscitello SVP, Chief People Officer - [O] | 85.683 | 85.683 | |
| David Roman President & CEO - [O] | 332.134 | 332.134 | |
| John F Sheridan Director - [D] | 24.347 | 24.347 | |
| Tom Sohn SVP, Gen. Counsel & Secretary - [O] | 105.009 | 105.009 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AFIB / Acutus Medical, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AFIB / Acutus Medical, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-03 | Huennekens R Scott | 60.000 | 0,5800 | 60.000 | 0,5800 | 34.800 | 14 | 0.4911 | -5.334 | -15,33 |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-04 | 2024-03-01 | 4 | Mukai Takeo | AFIB | Form 4 | D | 0,2100 | -8.475 | -2 | 72.874 | ||||
| 2024-02-07 | 2024-02-06 | 4 | Sohn Tom | AFIB | Form 4 | D | 0,1730 | -7.582 | -1 | 105.009 | ||||
| 2024-02-02 | 2024-02-01 | 4 | Mukai Takeo | AFIB | Form 4 | D | 0,1910 | -2.869 | -1 | 81.349 | ||||
| 2024-02-02 | 2024-02-01 | 4 | Sohn Tom | AFIB | Form 4 | D | 0,1910 | -5.709 | -1 | 112.591 | ||||
| 2024-01-18 | 2024-01-07 | 4 | Mathews Kevin | AFIB | Form 4 | D | 0,1890 | -6.342 | -1 | 61.106 | ||||
| 2024-01-18 | 2024-01-07 | 4 | Roman David | AFIB | Form 4 | D | 0,1890 | -24.086 | -5 | 332.134 | ||||
| 2023-09-05 | 2023-09-01 | 4 | Mukai Takeo | AFIB | FORM 4 | D | 0,4880 | -1.729 | -1 | 84.218 | ||||
| 2023-08-07 | 2023-08-05 | 4 | Sohn Tom | AFIB | FORM 4 | D | 0,6900 | -433 | -0 | 118.300 | ||||
| 2023-08-07 | 2023-08-05 | 4 | Mathews Kevin | AFIB | FORM 4 | D | 0,6900 | -134 | -0 | 67.448 | ||||
| 2023-08-02 | 2023-08-01 | 4 | Roman David | AFIB | FORM 4 | D | -6.484 | 356.220 | ||||||
| 2023-08-02 | 2023-08-01 | 4 | Sohn Tom | AFIB | FORM 4 | D | 20.000 | 118.733 | ||||||
| 2023-08-02 | 2023-08-02 | 4 | Mukai Takeo | AFIB | FORM 4 | D | -501 | 83.447 | ||||||
| 2023-06-29 | 2023-06-15 | 4/A | ElBardissi Andrew | AFIB | FORM 4 | D | 8.400 | 20.822 | ||||||
| 2023-06-20 | 2023-06-15 | 4 | Flynn James E Through Deerfield Management Company, L.P. | AFIB | Common Stock | I | 8.400 | 20.822 | ||||||
| 2023-06-20 | 2022-06-16 | 4 | Flynn James E Through Deerfield Management Company, L.P. | AFIB | Common Stock | I | 8.400 | 12.422 | ||||||
| 2023-06-15 | 2023-06-15 | 4 | Huennekens R Scott | AFIB | FORM 4 | D | 10.920 | 21.840 | ||||||
| 2023-06-15 | 2023-06-15 | 4 | Pellegrini Niamh Louise | AFIB | FORM 4 | D | 8.400 | 20.972 | ||||||
| 2023-06-15 | 2023-06-15 | 4 | Bonita David P | AFIB | FORM 4 | D | 8.400 | 20.822 | ||||||
| 2023-06-15 | 2023-06-15 | 4 | Sheridan John F | AFIB | FORM 4 | D | 8.400 | 24.347 | ||||||
| 2023-06-15 | 2023-06-15 | 4 | Garland Jason K | AFIB | FORM 4 | D | 8.400 | 22.400 | ||||||
| 2023-06-15 | 2023-06-15 | 4 | ElBardissi Andrew | AFIB | FORM 4 | D | 8.400 | 20.822 | ||||||
| 2023-06-15 | 2023-06-15 | 4 | Marzouk Shaden | AFIB | FORM 4 | D | 8.400 | 20.822 | ||||||
| 2023-06-01 | 2023-06-01 | 4 | Roman David | AFIB | FORM 4 | D | 0,8479 | -17.290 | -15 | 362.704 | ||||
| 2023-04-04 | 2023-04-01 | 4 | Sohn Tom | AFIB | FORM 4 | D | 0,7540 | -855 | -1 | 98.733 | ||||
| 2023-04-04 | 2023-04-01 | 4 | Piscitello Charlie | AFIB | FORM 4 | D | 0,7540 | -855 | -1 | 85.683 | ||||
| 2023-04-04 | 2023-04-01 | 4 | Roman David | AFIB | FORM 4 | D | 0,7540 | -3.165 | -2 | 379.994 | ||||
| 2023-04-04 | 2023-04-01 | 4 | Mathews Kevin | AFIB | FORM 4 | D | 0,7540 | -321 | -0 | 66.332 | ||||
| 2023-03-02 | 2023-03-01 | 4 | Sohn Tom | AFIB | FORM 4 | D | 42.500 | 99.588 | ||||||
| 2023-03-02 | 2023-03-01 | 4 | Mathews Kevin | AFIB | FORM 4 | D | 42.500 | 66.653 | ||||||
| 2023-03-02 | 2023-03-01 | 4 | Mukai Takeo | AFIB | FORM 4 | D | 47.500 | 83.948 | ||||||
| 2023-03-02 | 2023-03-01 | 4 | Roman David | AFIB | FORM 4 | D | 135.000 | 383.159 | ||||||
| 2023-03-02 | 2023-03-01 | 4 | Piscitello Charlie | AFIB | FORM 4 | D | 42.500 | 86.538 | ||||||
| 2023-02-02 | 2023-02-01 | 4 | Mathews Kevin | AFIB | FORM 4 | D | 1,8700 | -3.540 | -7 | 24.153 | ||||
| 2023-02-02 | 2023-02-01 | 4 | Piscitello Charlie | AFIB | FORM 4 | D | 1,8700 | -6.627 | -12 | 44.038 | ||||
| 2023-02-02 | 2023-02-01 | 4 | Sohn Tom | AFIB | FORM 4 | D | 1,8700 | -6.525 | -12 | 57.190 | ||||
| 2023-02-02 | 2023-02-01 | 4 | Roman David | AFIB | FORM 4 | D | 1,8700 | -10.196 | -19 | 248.159 | ||||
| 2023-02-02 | 2023-02-01 | 4 | Mukai Takeo | AFIB | FORM 4 | D | 1,8700 | -2.855 | -5 | 36.448 | ||||
| 2022-10-11 | 2022-10-01 | 4 | Huennekens R Scott | AFIB | Common Stock | D | 2.520 | 10.920 | ||||||
| 2022-09-02 | 2022-09-01 | 4 | Garland Jason K | AFIB | Common Stock | D | 14.000 | 14.000 | ||||||
| 2022-09-02 | 2022-09-01 | 4 | Mukai Takeo | AFIB | Common Stock | D | 20.000 | 39.303 | ||||||
| 2022-08-29 | 3 | Mukai Takeo | AFIB | Common Stock | D | 19.303 | ||||||||
| 2022-08-09 | 2022-08-05 | 4 | Sohn Tom | AFIB | Common Stock | D | 1,5600 | -433 | -1 | 63.613 | ||||
| 2022-08-09 | 2022-08-05 | 4 | Piscitello Charlie | AFIB | Common Stock | D | 1,5600 | -433 | -1 | 49.415 | ||||
| 2022-08-09 | 2022-08-05 | 4 | Mathews Kevin | AFIB | Common Stock | D | 1,5600 | -134 | -0 | 27.693 | ||||
| 2022-08-01 | 2022-08-01 | 4 | Roman David | AFIB | Common Stock | D | 75.000 | 258.355 | ||||||
| 2022-08-01 | 3 | Piscitello Charlie | AFIB | Common Stock | D | 49.848 | ||||||||
| 2022-08-01 | 3 | Sohn Tom | AFIB | Common Stock | D | 64.046 | ||||||||
| 2022-08-01 | 3 | Mathews Kevin | AFIB | Common Stock | D | 27.827 | ||||||||
| 2022-06-21 | 2022-06-16 | 4 | Sheridan John F | AFIB | Common Stock | D | 8.400 | 15.947 | ||||||
| 2022-06-21 | 2022-06-16 | 4 | Huennekens R Scott | AFIB | Common Stock | D | 8.400 | 8.400 | ||||||
| 2022-06-21 | 2022-06-16 | 4 | Hinrichs James F. | AFIB | Common Stock | D | 8.400 | 61.311 | ||||||
| 2022-06-21 | 2022-06-16 | 4 | Bonita David P | AFIB | Common Stock | D | 8.400 | 12.422 | ||||||
| 2022-06-21 | 2022-06-16 | 4 | Cramp Daniella | AFIB | Common Stock | D | 8.400 | 11.623 | ||||||
| 2022-06-21 | 2022-06-16 | 4 | Pellegrini Niamh Louise | AFIB | Common Stock | D | 8.400 | 12.572 | ||||||
| 2022-06-21 | 2022-06-16 | 4 | ElBardissi Andrew | AFIB | Common Stock | D | 8.400 | 12.422 | ||||||
| 2022-06-21 | 2022-06-16 | 4 | Marzouk Shaden | AFIB | Common Stock | D | 8.400 | 12.422 | ||||||
| 2022-06-03 | 2022-06-03 | 4 | Huennekens R Scott By Front Foot Trust | AFIB | Common Stock | I | 0,5800 | -60.000 | -35 | 507.509 | ||||
| 2022-06-02 | 2022-06-01 | 4 | Roman David | AFIB | Common Stock | D | 100.000 | 183.355 | ||||||
| 2022-04-05 | 2022-04-01 | 4 | Roman David | AFIB | Common Stock | D | 1,3000 | -3.248 | -4 | 83.355 | ||||
| 2022-04-05 | 2022-04-01 | 4 | Burgess Vincent J | AFIB | Common Stock | D | 1,3000 | -3.896 | -5 | 61.469 | ||||
| 2022-04-05 | 2022-04-01 | 4 | McQuillan Steven | AFIB | Common Stock | D | 1,3000 | -733 | -1 | 45.844 | ||||
| 2022-02-03 | 2022-02-01 | 4 | McQuillan Steven | AFIB | Stock Options (Right to Buy) | D | 2,41 | 32.000 | 32.000 | |||||
| 2022-02-03 | 2022-02-01 | 4 | McQuillan Steven | AFIB | Common Stock | D | 32.000 | 46.577 | ||||||
| 2022-02-03 | 2022-02-01 | 4 | Roman David | AFIB | Stock Options (Right to Buy) | D | 2,41 | 50.000 | 50.000 | |||||
| 2022-02-03 | 2022-02-01 | 4 | Roman David | AFIB | Common Stock | D | 50.000 | 86.603 | ||||||
| 2021-11-17 | 2021-11-15 | 4 | Hinrichs James F. | AFIB | Common Stock | D | 3,7805 | 40.000 | 151 | 52.911 | ||||
| 2021-09-02 | 2021-06-17 | 4 | Flynn James E Through Deerfield Management Company, L.P. | AFIB | Stock Option (Right to Buy) | I | 16,66 | 7.022 | 7.022 | |||||
| 2021-09-02 | 2021-06-17 | 4 | Flynn James E Through Deerfield Management Company, L.P. | AFIB | Common Stock | I | 1.800 | 4.022 | ||||||
| 2021-08-27 | 2021-08-05 | 4 | Burgess Vincent J | AFIB | Common Stock | D | 15,5200 | -1.922 | -30 | 65.365 | ||||
| 2021-08-27 | 2021-08-05 | 4 | McQuillan Steven | AFIB | Common Stock | D | 15,5200 | -305 | -5 | 14.577 | ||||
| 2021-08-12 | 2021-08-10 | 4 | Pellegrini Niamh Louise | AFIB | Stock Options (Right to Buy) | D | 14,38 | 15.191 | 15.191 | |||||
| 2021-08-12 | 2021-08-10 | 4 | Pellegrini Niamh Louise | AFIB | Common Stock | D | 4.172 | 4.172 | ||||||
| 2021-07-21 | 2021-07-19 | 4 | ORBIMED ADVISORS LLC See Footnotes | AFIB | Common Stock | I | 14,0000 | 357.143 | 5.000 | 1.677.361 | ||||
| 2021-07-21 | 2021-07-19 | 4 | ORBIMED ADVISORS LLC See Footnotes | AFIB | Common Stock | I | 14,0000 | 714.285 | 10.000 | 4.872.025 | ||||
| 2021-07-21 | 2021-07-19 | 4 | Bonita David P See Footnotes | AFIB | Common Stock | I | 14,0000 | 357.143 | 5.000 | 1.677.361 | ||||
| 2021-07-21 | 2021-07-19 | 4 | Bonita David P See Footnotes | AFIB | Common Stock | I | 14,0000 | 714.285 | 10.000 | 4.872.025 | ||||
| 2021-07-21 | 2021-07-19 | 4 | Flynn James E Through Deerfield Private Design Fund III, L.P. | AFIB | Common Stock | I | 14,0000 | 680.592 | 9.528 | 3.438.589 | ||||
| 2021-07-21 | 2021-07-19 | 4 | Flynn James E Through Deerfield Partners, L.P. | AFIB | Common Stock | I | 14,0000 | 390.836 | 5.472 | 1.974.638 | ||||
| 2021-06-22 | 2021-06-17 | 4 | Hinrichs James F. | AFIB | Stock Options (Right to Buy) | D | 16,66 | 7.022 | 7.022 | |||||
| 2021-06-22 | 2021-06-17 | 4 | Hinrichs James F. | AFIB | Common Stock | D | 1.800 | 12.911 | ||||||
| 2021-06-22 | 2021-06-17 | 4 | Marzouk Shaden | AFIB | Stock Options (Right to Buy) | D | 16,66 | 7.022 | 7.022 | |||||
| 2021-06-22 | 2021-06-17 | 4 | Marzouk Shaden | AFIB | Common Stock | D | 1.800 | 4.022 | ||||||
| 2021-06-22 | 2021-06-17 | 4 | Malik Shahzad | AFIB | Stock Options (Right to Buy) | D | 16,66 | 7.022 | 7.022 | |||||
| 2021-06-22 | 2021-06-17 | 4 | Malik Shahzad | AFIB | Common Stock | D | 1.800 | 4.022 | ||||||
| 2021-06-22 | 2021-06-17 | 4 | ElBardissi Andrew | AFIB | Stock Options (Right to Buy) | D | 16,66 | 7.022 | 7.022 | |||||
| 2021-06-22 | 2021-06-17 | 4 | ElBardissi Andrew | AFIB | Common Stock | D | 1.800 | 4.022 | ||||||
| 2021-06-22 | 2021-06-17 | 4 | Bonita David P | AFIB | Stock Options (Right to Buy) | D | 16,66 | 7.022 | 7.022 | |||||
| 2021-06-22 | 2021-06-17 | 4 | Bonita David P | AFIB | Common Stock | D | 1.800 | 4.022 | ||||||
| 2021-04-02 | 2021-04-01 | 4 | Roman David | AFIB | Stock Options (Right to Buy) | D | 13,66 | 77.335 | 77.335 | |||||
| 2021-04-02 | 2021-04-01 | 4 | Roman David | AFIB | Common Stock | D | 36.603 | 36.603 | ||||||
| 2021-04-02 | 2021-04-01 | 4 | McQuillan Steven | AFIB | Stock Options (Right to Buy) | D | 13,66 | 34.800 | 34.800 | |||||
| 2021-04-02 | 2021-04-01 | 4 | McQuillan Steven | AFIB | Common Stock | D | 9.882 | 14.882 | ||||||
| 2021-04-02 | 2021-04-01 | 4 | Burgess Vincent J | AFIB | Stock Options (Right to Buy) | D | 13,66 | 158.691 | 158.691 | |||||
| 2021-04-02 | 2021-04-01 | 4 | Burgess Vincent J | AFIB | Common Stock | D | 45.065 | 67.287 | ||||||
| 2021-03-19 | 2021-03-17 | 4 | Sheridan John F | AFIB | Stock Options (Right to Buy) | D | 19,06 | 10.882 | 10.882 | |||||
| 2021-03-19 | 2021-03-17 | 4 | Sheridan John F | AFIB | Common Stock | D | 3.147 | 7.547 | ||||||
| 2021-03-19 | 3 | Sheridan John F | AFIB | Common Stock | D | 4.400 | ||||||||
| 2021-02-12 | 3 | McQuillan Steven | AFIB | Common Stock | D | 5.000 | ||||||||
| 2021-02-05 | 2021-02-03 | 4 | Cramp Daniella | AFIB | Stock Options (Right to Buy) | D | 24,76 | 9.972 | 9.972 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Cramp Daniella | AFIB | Common Stock | D | 2.423 | 3.223 | ||||||
| 2021-02-05 | 3 | Cramp Daniella | AFIB | Common Stock | D | 800 | ||||||||
| 2020-08-12 | 2020-08-10 | 4 | Hinrichs James F. | AFIB | Common Stock | D | 18,0000 | 10.000 | 180 | 11.111 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Barnickel John | AFIB | Common Stock | D | 18,0000 | 7.300 | 131 | 13.966 | ||||
| 2020-08-12 | 2020-08-10 | 4 | ORBIMED ADVISORS LLC See footnotes | AFIB | Series D Convertible Preferred Stock | I | 0,00 | -378.733 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | ORBIMED ADVISORS LLC See footnotes | AFIB | Series D Convertible Preferred Stock | I | 0,00 | -1.202.117 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | ORBIMED ADVISORS LLC See footnotes | AFIB | Series D Convertible Preferred Stock | I | 0,00 | -389.116 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | ORBIMED ADVISORS LLC See footnotes | AFIB | Series C Convertible Preferred Stock | I | 0,00 | -899.985 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | ORBIMED ADVISORS LLC See footnotes | AFIB | Series C Convertible Preferred Stock | I | 0,00 | -647.582 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | ORBIMED ADVISORS LLC See footnotes | AFIB | Series B Convertible Preferred Stock | I | 0,00 | -673.123 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | ORBIMED ADVISORS LLC See footnotes | AFIB | Series B Convertible Preferred Stock | I | 0,00 | -872.302 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | ORBIMED ADVISORS LLC See footnotes | AFIB | Common Stock | I | 1.278.718 | 1.320.218 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | ORBIMED ADVISORS LLC See footnotes | AFIB | Common Stock | I | 3.784.240 | 4.157.740 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | ORBIMED ADVISORS LLC See footnotes | AFIB | Common Stock | I | 18,0000 | 41.500 | 747 | 41.500 | ||||
| 2020-08-12 | 2020-08-10 | 4 | ORBIMED ADVISORS LLC See footnotes | AFIB | Common Stock | I | 18,0000 | 373.500 | 6.723 | 373.500 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Bonita David P See footnotes | AFIB | Series D Convertible Preferred Stock | I | 0,00 | -378.733 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Bonita David P See footnotes | AFIB | Series D Convertible Preferred Stock | I | 0,00 | -1.202.117 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Bonita David P See footnotes | AFIB | Series D Convertible Preferred Stock | I | 0,00 | -389.116 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Bonita David P See footnotes | AFIB | Series C Convertible Preferred Stock | I | 0,00 | -899.985 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Bonita David P See footnotes | AFIB | Series C Convertible Preferred Stock | I | 0,00 | -647.582 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Bonita David P See footnotes | AFIB | Series B Convertible Preferred Stock | I | 0,00 | -673.123 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Bonita David P See footnotes | AFIB | Series B Convertible Preferred Stock | I | 0,00 | -872.302 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Bonita David P See footnotes | AFIB | Common Stock | I | 1.278.718 | 1.320.218 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | Bonita David P See footnotes | AFIB | Common Stock | I | 3.784.240 | 4.157.740 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | Bonita David P See footnotes | AFIB | Common Stock | I | 18,0000 | 41.500 | 747 | 41.500 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Bonita David P See footnotes | AFIB | Common Stock | I | 18,0000 | 373.500 | 6.723 | 373.500 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Malik Shahzad | AFIB | Series D Convertible Preferred Stock | I | 0,00 | -171.695 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Malik Shahzad | AFIB | Series D Convertible Preferred Stock | I | 0,00 | -7.242 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Malik Shahzad | AFIB | Series C Convertible Preferred Stock | I | 0,00 | -312.840 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Malik Shahzad | AFIB | Series C Convertible Preferred Stock | I | 0,00 | -13.195 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Malik Shahzad | AFIB | Series B Convertible Preferred Stock | I | 0,00 | -812.683 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Malik Shahzad | AFIB | Series B Convertible Preferred Stock | I | 0,00 | -34.261 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Malik Shahzad | AFIB | Series A Convertible Preferred Stock | I | 0,00 | -254.495 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Malik Shahzad | AFIB | Series A Convertible Preferred Stock | I | 0,00 | -10.738 | 0 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Malik Shahzad | AFIB | Common Stock | I | 1.551.713 | 1.551.713 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | Malik Shahzad | AFIB | Common Stock | I | 65.436 | 65.436 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | Flynn James E Through Deerfield Private Design Fund III, L.P. | AFIB | Series D Preferred Stock | I | -1.002.464 | 0 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | Flynn James E Through Deerfield Partners, L.P. | AFIB | Series D Preferred Stock | I | -189.366 | 0 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | Flynn James E Through Deerfield Private Design Fund III, L.P. | AFIB | Series C Preferred Stock | I | -1.199.980 | 0 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | Flynn James E Through Deerfield Partners, L.P. | AFIB | Series C Preferred Stock | I | -449.992 | 0 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | Flynn James E Through Deerfield Private Design Fund III, L.P. | AFIB | Common Stock | I | 18,0000 | 555.556 | 10.000 | 2.758.000 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Flynn James E Through Deerfield Partners, L.P. | AFIB | Common Stock | I | 18,0000 | 944.444 | 17.000 | 1.583.802 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Flynn James E Through Deerfield Private Design Fund III, L.P. | AFIB | Common Stock | I | 1.002.464 | 2.202.444 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | Flynn James E Through Deerfield Partners, L.P. | AFIB | Common Stock | I | 189.366 | 639.358 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | Flynn James E Through Deerfield Private Design Fund III, L.P. | AFIB | Common Stock | I | 1.199.980 | 1.199.980 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | Flynn James E Through Deerfield Partners, L.P. | AFIB | Common Stock | I | 449.992 | 449.992 | ||||||
| 2020-08-12 | 2020-08-05 | 4 | Flynn James E Through Deerfield Management Company, L.P. | AFIB | Stock Options (Right to Buy) | I | 18,00 | 12.454 | 12.454 | |||||
| 2020-08-12 | 2020-08-05 | 4 | Flynn James E Through Deerfield Management Company, L.P. | AFIB | Common Stock | I | 2.222 | 2.222 | ||||||
| 2020-08-07 | 2020-08-05 | 4 | Bonita David P | AFIB | Stock Options (Right to Buy) | D | 18,00 | 12.454 | 12.454 | |||||
| 2020-08-07 | 2020-08-05 | 4 | Bonita David P | AFIB | Common Stock | D | 2.222 | 2.222 | ||||||
| 2020-08-07 | 2020-08-05 | 4 | Burgess Vincent J | AFIB | Stock Options (Right to Buy) | D | 18,00 | 124.542 | 124.542 | |||||
| 2020-08-07 | 2020-08-05 | 4 | Burgess Vincent J | AFIB | Common Stock | D | 22.222 | 22.222 | ||||||
| 2020-08-07 | 2020-08-05 | 4 | Barnickel John | AFIB | Stock Options (Right to Buy) | D | 18,00 | 153.569 | 153.569 | |||||
| 2020-08-07 | 2020-08-05 | 4 | Barnickel John | AFIB | Common Stock | D | 6.666 | 6.666 | ||||||
| 2020-08-07 | 2020-08-05 | 4 | ElBardissi Andrew | AFIB | Stock Options (Right to Buy) | D | 18,00 | 12.454 | 12.454 | |||||
| 2020-08-07 | 2020-08-05 | 4 | ElBardissi Andrew | AFIB | Common Stock | D | 2.222 | 2.222 | ||||||
| 2020-08-07 | 2020-08-05 | 4 | Marzouk Shaden | AFIB | Stock Options (Right to Buy) | D | 18,00 | 12.454 | 12.454 | |||||
| 2020-08-07 | 2020-08-05 | 4 | Marzouk Shaden | AFIB | Common Stock | D | 2.222 | 2.222 | ||||||
| 2020-08-07 | 2020-08-05 | 4 | Malik Shahzad | AFIB | Stock Options (Right to Buy) | D | 18,00 | 12.454 | 12.454 | |||||
| 2020-08-07 | 2020-08-05 | 4 | Malik Shahzad | AFIB | Common Stock | D | 2.222 | 2.222 | ||||||
| 2020-08-07 | 2020-08-05 | 4 | Hinrichs James F. | AFIB | Stock Options (Right to Buy) | D | 18,00 | 6.227 | 6.227 | |||||
| 2020-08-07 | 2020-08-05 | 4 | Hinrichs James F. | AFIB | Common Stock | D | 1.111 | 1.111 | ||||||
| 2020-08-07 | 2020-08-05 | 4 | Doherty Gary W. | AFIB | Stock Options (Right to Buy) | D | 18,00 | 28.022 | 28.022 | |||||
| 2020-08-07 | 2020-08-05 | 4 | Doherty Gary W. | AFIB | Common Stock | D | 5.000 | 5.000 | ||||||
| 2020-08-05 | 3 | Hinrichs James F. By Hinrichs Joint Revocable Trust | AFIB | Common Stock | I | 29.998 | ||||||||
| 2020-08-05 | 3 | Hinrichs James F. By Hinrichs Joint Revocable Trust | AFIB | Common Stock | I | 29.998 | ||||||||
| 2020-08-05 | 3 | Hinrichs James F. By Hinrichs Joint Revocable Trust | AFIB | Common Stock | I | 29.998 | ||||||||
| 2020-08-05 | 3 | Huennekens R Scott | AFIB | Common Stock | D | 1.135.018 | ||||||||
| 2020-08-05 | 3 | Huennekens R Scott | AFIB | Common Stock | D | 1.135.018 | ||||||||
| 2020-08-05 | 3 | Huennekens R Scott | AFIB | Common Stock | D | 1.135.018 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
